Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion type Assertion NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_head.
- NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion description "[While in advanced MDS (refractory anemia with excess blasts in transformation [RAEB-T] and tAML [MDS transformed into AML]), colony numbers decreased in the presence of TRAIL (63.0% +/- 10.4% of untreated group [100%]), numbers increased in patients with RA or RAEB (160.2% +/- 90.5% of untreated group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_provenance.
- NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion evidence source_evidence_literature NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_provenance.
- NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion SIO_000772 11698291 NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_provenance.
- NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion wasDerivedFrom befree-2016 NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_provenance.
- NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_assertion wasGeneratedBy ECO_0000203 NP335570.RA32_NWjYujVs67wT4a_93yxMw6ULkSGpmuLXXSV_u-PM130_provenance.